Doxazosin and Carvedilol Treatment Improves Hepatic Regeneration in a Hamster Model of Cirrhosis

Abstract EN

Regulation of the mechanisms of fibrosis is an important goal in the treatment of liver cirrhosis.

One mechanism is the participation of hepatic stellate cells in fibrogenesis when activated by catecholamines.

Consequently, α/β adrenoblockers are proposed as an alternative treatment for chronic liver lesions such as fibrosis and/or cirrhosis and for possible liver regeneration.

We herein analyzed the effect of doxazosin and carvedilol treatments during the regeneration of tissue in a hamster model of liver cirrhosis.

Tissue samples were examined by H&E and PAS to evaluate tissue damage and with Sirius red to assess collagen fiber content.

ALT, AST, albumin, and total proteins were examined by spectrophotometry.

Determination of the levels of α-SMA and TGF-β in hepatic tissue was examined by Western blot and of the expression of TIMP-2, MMP-13, α-FP, HGF, CK-7, and c-Myc was examined by qPCR.

Treatment with doxazosin or carvedilol prompted histological recovery and reduced collagen fibers in the livers of cirrhotic hamsters.

The expression of TIMP-2 decreased and that of MMP-13 increases in animals treated with adrenoblockers with respect to the group with cirrhosis.

Additionally, the concentration of α-SMA and TGF-β declined with both drugs with respect to placebo p<0.05.

On the other hand, each drug treatment led to a distinct scenario for cell proliferation markers.

Whereas doxazosin produced no irregularities in α-FP, Ki-67, and c-Myc expression, carvedilol induced an increment in the expression of these markers with respect to the intact.

Hence, doxazosin and carvedilol are potential treatments for the regression of hepatic cirrhosis in hamsters in relation to the decrease of collagen in the hepatic parenchyma.

However, at regeneration level we observed that doxazosin caused slight morphological changes in hepatocytes, such as its balonization without affecting the hepatic function, and on the other hand, carvedilol elicited a slight irregular expression of cell proliferation markers.